Encrypted AI-powered drug repurposing
At DeepScript, we’re accelerating drug discovery by combining automated high-throughput screening with AI-driven biological profiling to predict compound biological activity with unprecedented accuracy.
Our DeepMatch platform leverages deep learning algorithms to generate encrypted biological fingerprints of small molecules, enabling secure and cost-effective candidate discovery. With access to a unique growing database of partner compounds, we’re unlocking new opportunities for drug repurposing and target identification.
